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Abstract
The Wisconsin Clinical Laboratory Network (WCLN) at the University of Wisconsin–Madison is a partnership of
138 clinical and public health laboratories (as of February 2019) coordinated by the Wisconsin State Laboratory
of Hygiene. This article describes the WCLN, its current activities, and lessons learned through this partnership. A
laboratory technical advisory group, which consists of representatives from clinical laboratories, provides clinical
laboratory perspective to the WCLN and fosters communication among laboratories. Activities and resources
available through the WCLN include annual regional meetings, annual technical workshops, webinars, an email
listserv, laboratory informational messages, in-person visits by a WCLN coordinator to clinical laboratories, and
laboratory-based surveillance data and summaries distributed by the Wisconsin State Laboratory of Hygiene.
One challenge to maintaining the WCLN is securing continual funding for network activities. Key lessons learned
from this partnership of more than 20 years include the importance of in-person meetings, the clinical
perspective of the laboratory technical advisory group, and providing activities and resources to clinical
laboratories to foster sharing of data and clinical specimens for public health surveillance and outbreak
response.
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Clinical laboratories are important partners in any well-functioning public health laboratory system, and
laboratory networks provide vital data and clinical specimens for detailed characterization to monitor and
respond to public health concerns. However, studies examining approaches to strengthening relationships
between public health laboratories and clinical laboratories are scarce. The Wisconsin State Laboratory of
Hygiene (WSLH) at the University of Wisconsin–Madison recognized the importance of networks more than 20
years ago and has reached out to more than 130 clinical laboratories and public health laboratories to develop
the Wisconsin Clinical Laboratory Network (WCLN). The purpose of the WCLN is to provide communication
channels and support among clinical laboratories and public health laboratories to create a strong public health
laboratory system to better serve the health of Wisconsin residents. The WCLN, which is coordinated and
funded by WSLH primarily through general state funds, promotes an exchange of ideas, fosters collaboration
among WCLN members, and serves as a model for other states seeking to conduct similar activities.

The first laboratory networks in Wisconsin, the precursors to the WCLN, were focused on virology and
mycobacteriology and involved a limited number of clinical laboratories.1,2 After 9/11, the network was
expanded to include all clinical laboratories and public health laboratories in the state, with an emphasis on
emergency preparedness and response. The WCLN now encompasses training, enhanced communications, and
public health surveillance. The network’s 138 participants include 137 clinical laboratories from across the state
and the Milwaukee Public Health Laboratory; the WCLN is coordinated by WSLH. Because most WCLN
laboratories are clinical laboratories, we refer hereinafter to the member laboratories as “clinical laboratories,”
but this term also covers the Milwaukee Public Health Laboratory.
We describe the WCLN, its current activities, additional projects, and lessons learned through this partnership.3

Methods
WCLN History

Virology and mycobacteriology laboratory networks were established in 1995 and 1997,
respectively,1,2,4 with annual conferences held to share statewide best practices, distribute educational
materials, and discuss issues affecting clinical laboratories. Because of concerns about bioterrorism and
all-hazards preparedness after 9/11, these networks evolved into what is now the WCLN. Early
activities of the WCLN included site visits to clinical laboratories to distribute educational materials
about emergency response, packaging and shipping of specimens, and biothreat agent testing. Other
early activities involved biothreat agent testing exercises to improve clinical laboratories' capacity to
identify or rule out biothreat agents. The exercises were similar to proficiency testing (ie, testing
conducted by an external organization to determine a laboratory’s ability to produce accurate results)
and were followed by an audioconference and written summary of how laboratories performed on the
challenge. A practical how-to guide for setting up laboratory networks was also developed and is
available elsewhere.4

Laboratory Technical Advisory Group

The Laboratory Technical Advisory Group (LabTAG), which consists of 10-12 clinical laboratorians from
throughout Wisconsin, advises the WCLN and drives much of the network’s educational and training agenda.
The mission of LabTAG is “to collaborate with WSLH, with an emphasis on infectious disease diagnosis,
biosafety, training, and public health emergency preparedness, to improve the state of Wisconsin’s clinical
laboratory system, both public and private, and support the purpose of the WCLN.”5 LabTAG includes 1 member
from each of 7 designated WCLN regions across Wisconsin (ie, regions into which the Wisconsin Department of
Health Services divided the state to streamline the distribution of local preparedness funding), plus at-large
members. WCLN laboratorians volunteer to be LabTAG members for 3 years; at-large members (often clinical
microbiologists with a doctoral degree) serve for extended periods, if they are willing.
LabTAG members participate in monthly and special project conference calls, attend an annual in-person
LabTAG meeting, and serve as speakers during WCLN educational activities. LabTAG members represent the
clinical laboratories in their region of Wisconsin and act as points of contact for laboratories to relay input and
feedback to the WCLN. LabTAG’s clinical laboratory perspective ensures that the WCLN is a partnership between
clinical laboratories and public health laboratories and that the WCLN is not driven solely by the interest of
WSLH. WSLH staff members facilitate LabTAG meetings and direct discussions, but clinical laboratory members
provide input and make decisions.

WCLN Activities

Activities of the WCLN fall into 4 main categories: training and education, facilitating communication, public
health surveillance, and emergency response. To address training and education, the WCLN provides continuing
education credits (Professional Acknowledgment for Continuing Education [PACE]) through webinars and several
full-day training events throughout the year. LabTAG helps plan training events, and members frequently serve
as speakers and subject matter experts. LabTAG members and WSLH staff members attend a 1-day technical
workshop every spring; recent topics have included antimicrobial susceptibility testing and molecular
diagnostics. One-day training sessions are also held in the summer, with the topic alternating each year between
performance and interpretation of Gram stains and training in packaging and shipping specimens. One-day
conferences on virology and mycobacteriology are held annually, and 1-day WCLN regional meetings are held
each fall in 3 locations around the state. Regional meetings include lectures and discussions on topics of interest,
surveillance updates from WSLH, and progress reports on additional projects, such as a recent statewide
assessment of biosafety practices.6 WSLH coordinates annual webinars, and speakers include WSLH staff
members, LabTAG members, and invited speakers. During meetings and webinars, WCLN members suggest
topics for future meetings and webinars to ensure the input of laboratory members outside of LabTAG.
Multiple activities facilitate communication among WCLN members. The workshops, trainings, and regional
meetings provide in-person networking opportunities, and there is no cost to attend. Local and state public
health epidemiologists and infection preventionists are present at several of these activities. WSLH sends a
monthly newsletter to all WCLN laboratories to share information or guidance, announce WCLN activities, and
highlight recent news items. WSLH coordinates an email listserv for clinical laboratorians to use to discuss
technical issues among members of the Wisconsin laboratory community. Lastly, the WCLN coordinator, a WSLH
employee with a clinical laboratory background whose full-time job is that of coordinator, visits 10-20 clinical
laboratories each year to stay current with the needs and challenges of clinical laboratories and to foster
personal connections with clinical laboratorians, management, and medical directors.
Clinical laboratories provide surveillance data, samples, and bacterial isolates to WSLH. WSLH then collates the
data and shares them with clinical laboratories, by posting surveillance reports on the WSLH website7 and in
weekly email summaries. This surveillance encompasses bacteriology (antibiotic-resistant bacteria and invasive
bacterial infections), mycobacteriology, virology (influenza and other respiratory pathogens), and molecular
gastropathogen surveillance.
During regional meetings, WSLH covers emergency preparedness and response topics such as biosafety,
biosecurity, and packaging and shipping of specimens. WSLH also coordinates annual emergency response
communication drills in which messages are sent from WSLH to clinical laboratories, and the times of both
message receipt and response to WSLH are tracked. Lastly, WSLH offers biannual bioterrorism agent testing
exercises free of charge to clinical laboratories.

Outcomes
Summary of Activities

Since its inception, the WCLN has held 27 virology meetings, 20 mycobacteriology meetings, and 15 annual
WCLN regional meetings (since 2004), each with 30-100 attendees. Monthly teleconferences have been held
since 2001. As part of coordinating the WCLN, WSLH has sent more than 350 newsletters, shared regular
surveillance summaries for more than 20 years, provided proficiency testing challenges at least annually since
2001, and led emergency response communication drills annually since 2002.

Communication

Achieving the WCLN’s original goal of fostering communication among laboratories across Wisconsin has paid
many dividends. In our experience, the personal connections made through WCLN reduce barriers to
conversation and ensure smooth communication among laboratories despite a competitive fiscal environment
and frequent acquisitions and consolidations. WCLN communications from WSLH to clinical laboratories have
been leveraged many times for outbreak response, including a pertussis outbreak during 2003-2004,8 the H1N1
influenza pandemic of 2009, Ebola preparedness in 2014, and an outbreak of Elizabethkingia in 2016.9
Communication from clinical laboratories to WSLH is also strong: clinical laboratories look to WSLH for guidance
in instances of cross-contamination, false-positive mycobacteria results, and an outbreak or public health
concern. For example, the director of a clinical laboratory reached out to WSLH the same day a
Methylobacterium isolate was presumptively identified and associated with a contaminated lot of hyaluronic
acid,10 which allowed WSLH to issue a timely informational memorandum alerting clinical laboratories to this
association.

Platform for Additional Projects

The WCLN is useful for addressing biosafety and the need for a statewide summary of antimicrobial resistance
patterns. Biosafety has been a recent priority because of the 2014 Ebola outbreak and funding from CDC to
bolster biosafety practices in laboratories. As part of this focus on biosafety, in 2015, WSLH coordinated a
statewide assessment of biosafety practices in more than 100 clinical laboratories in Wisconsin.6 The WCLN
infrastructure was essential in facilitating laboratory participation in this project, and a follow-up assessment is
underway to determine if progress has been made to fill gaps in biosafety.
The WCLN has also been used for antimicrobial resistance projects. After the 2014 annual LabTAG meeting,
LabTAG members were charged with requesting a facility-specific antibiogram (ie, a table summarizing the
percentage of bacterial pathogens susceptible to various antibiotics) from each WCLN facility in their region.
Antibiograms from 72 WCLN entities were forwarded to a central LabTAG contact for data compilation and
analysis at the state level and in the 7 WCLN regions. An analysis of more than 150 000 organism-antimicrobial
combinations revealed geographic differences in antimicrobial resistance in Wisconsin.11
The initial antibiogram work formed the basis for the Surveillance of Wisconsin Organisms for Trends in
Antimicrobial Resistance and Epidemiology (SWOTARE) program. Potential limitations of the antibiogram-based
surveillance include procurement of primary data for the antibiogram (particularly as it relates to variability in
local susceptibility testing),12-15 construction of the antibiogram,16-18 and the fact that not all antibiograms from
the previous Wisconsin study11 contained common organisms and/or antimicrobial agents. To avoid these
issues, SWOTARE was developed to systematically assess antimicrobial resistance patterns by using a single
standardized testing facility.19 The WCLN’s infrastructure helped facilitate SWOTARE; the WCLN leveraged its
connections to recruit study sites. Three microbiology laboratories in each WCLN region forward quotas of
clinically important organisms annually to a centralized testing facility, which uses a reference broth
microdilution method20 to compare resistance profiles by location and time. Study sites are also asked to
provide limited demographic information with each submitted isolate, so that epidemiologic associations with
antimicrobial resistance in Wisconsin can be investigated.21

Lessons Learned
Value-Added Resources

The WCLN has helped strengthen public health surveillance and outbreak response in Wisconsin. To support the
WCLN, the WSLH has provided training, education, fee-exempt testing, and surveillance summaries to clinical
laboratories, which has increased clinical laboratory participation in sharing data and clinical specimens with
WSLH for surveillance and outbreak response. For example, WSLH received isolates from 100% of 89 cultureconfirmed tuberculosis cases identified in 2016 and 2017 and isolates or specimens from 3871 of 3983 (97%)
reported Salmonella, Shiga toxin-producing Escherichia coli, and Listeria cases in 2015 through 2017. Clinical
laboratory participation in WSLH requests to share data and clinical specimens has led to robust surveillance,
which has benefited both the WSLH and state epidemiologists.
LabTAG is crucial to the WCLN’s success. Allowing LabTAG members a strong voice in discussions and
establishing agendas ensures that network activities are relevant and beneficial to all clinical laboratories.
In-person meetings and site visits by the WCLN coordinator to clinical laboratories and annual in-person
meetings also contribute to the success of the WCLN. The in-person nature of LabTAG meetings fosters personal
connections that facilitate group functions for the rest of the year, when meetings are held by conference call
only. Furthermore, the rate of brainstorming and collaborative nature of the in-person meetings allow for rapid
progress; during the 1-day meeting, the previous year’s activities are reviewed in detail and the next year’s
activities are planned.
The direct laboratory-to-laboratory communication between WSLH and clinical laboratories is also important. It
enables WSLH to receive necessary data and specimens without overly burdening clinical laboratories. WSLH
does not share clinical laboratory contact information with other agencies; rather, WSLH acts as the
intermediary when other agencies seek to contact WCLN members.

Logistics of Network Facilitation by WSLH

Three important logistical aspects of WSLH’s network coordination are (1) having a WCLN coordinator, (2)
providing fee-exempt materials to ship surveillance specimens, and (3) offering complementary testing to
clinical laboratories. The WCLN coordinator is critically important to the function of the WCLN. The coordinator
must have a clinical background to relate to clinical laboratory experiences and culture. It is also important that
WSLH provides fee-exempt specimen collection kits and specimen transport, because providing them eliminates
barriers for clinical laboratories to contribute specimens to WSLH for ongoing surveillance. Finally, to be the best
possible partner with clinical laboratories and engender goodwill and continued partnership through the WCLN,
WSLH does not compete with clinical laboratories for diagnostic testing; rather, it offers complementary testing,
with the knowledge that competing with clinical laboratories for testing does not engender cooperation.

Challenges to Maintaining the WCLN

One challenge to maintaining the WCLN is securing funding for network activities. The WSLH recognizes the
importance of the WCLN to its work as the state’s public health laboratory. As such, continued support and
funding of the network are a WSLH priority, but securing consistent funding can be a challenge. Another
challenge to maintaining the network is clinical laboratory consolidation and “leaning,” or doing more work with
fewer people, which makes it difficult for clinical laboratorians to attend WCLN activities. However, providing
PACE credits for trainings, meetings, and webinars adds value; as such, supervisors are more likely to approve
time off to attend them. Another challenge with consolidation is that fewer laboratories perform microbiology
testing now than in the past. Because the WCLN is necessarily focused on microbiology for infectious disease
surveillance, outbreak response, and biothreat preparedness, the WCLN is beginning to lose its relevance for
laboratories that no longer perform microbiological testing. To address this issue, the network is considering

ways to engage generalists in additional clinical laboratory disciplines, including inviting non-microbiology
experts to give webinars.

Conclusions
The WCLN can serve as a model for other public health laboratorians looking to implement laboratory networks
in their states. The WCLN has been important to the mission of WSLH during the past 2 decades. Despite
challenges, ongoing support from both clinical laboratories and WSLH indicates that the network will continue to
be useful in the future.
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